Meanwhile, Api receivers showed markedly mitigated HFD-induced blood glucose increase accompanied by improvement in insulin resistance (Figures 5G,H), ameliorated dyslipidemia (Figure 5I), restoration of liver injury (Figure 5J), and improved inflammatory cytokines in serum (Figure 5K). Here, SERPINF2 is linked to Insulin resistance.